Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Kardigan, Inc.

NASDAQ: KARD · Life Sciences · 4 alerts · CIK 2123613

Share price
$12.85Close, Nov 16
Market cap
$1.2B
Shares outstanding
93.6MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Kardigan, Inc. filings on SEC EDGAR ↗

4:07 PM ET 8-K
Business Update

Kardigan Business Update

Kardigan, Inc. has completed enrollment for its Phase 2b KATALYST-AV trial evaluating ataciguat in patients with aortic stenosis. The company also updated its trial protocol to assess the primary endpoint of aortic valve calcium at week 48 instead of earlier, based on real-world data analysis of disease progression. Topline data from the trial is now expected in the second half of 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.